Featured Research

from universities, journals, and other organizations

Engineered protein fragment blocks the AIDS virus from entering cells

Date:
April 2, 2011
Source:
Federation of American Societies for Experimental Biology
Summary:
In what could be a potential breakthrough in the battle against AIDS and a major development in the rational design of new drugs, scientists have engineered a new protein that prevents the virus from entering cells.

In what could be a potential breakthrough in the battle against AIDS and a major development in the rational design of new drugs, scientists have engineered a new protein that prevents the virus from entering cells. This protein is based on a naturally occurring protein in the body that protects cells from viruses, except the human-made version does not cause inflammation and other side effects at the dosages needed to inhibit AIDS.

This discovery was published in the April 2011 issue of The FASEB Journal.

"This is science fiction made reality. These researchers took a protein apart and removed the portion that causes harm, then stabilized and modified the section that has a therapeutic effect," said Gerald Weissmann, M.D., Editor-in-Chief of The FASEB Journal. "Not only is this good news for people with AIDS, it's good news for all of us as this research paves the way for similar work for many, many other illnesses."

The protein fragment is based on a naturally occurring protein called RANTES, which is part of the body's immune system. RANTES naturally defends the body against HIV/AIDS, but cannot be used as a drug or drug candidate because it has several other biological effects which could cause harmful inflammation. After examining the precise molecular structure of the RANTES protein, the researchers discovered that only a small fragment of the RANTES protein is actually responsible for blocking HIV entry into cells. From there, they dissected the desired section of the RANTES protein and worked to stabilize it without compromising its protective effects.

After several sequential steps of molecular refinement and some virtual modeling, the researchers created a peptide with very high potency against HIV, with possible benefits for treating inflammatory diseases such as arthritis and lupus, as well as the prevention of transplant rejection.

"We're finally able to design smart anti-HIV drugs aimed at the right target. That's because scientists have spent decades figuring out the molecular details of how the virus enters cells, and the exact chemical structures involved," Weissmann added. "As the Renaissance sculptors wrought art from crude marble, today's molecular engineers ... use intelligent design to create life-saving chemical masterpieces."


Story Source:

The above story is based on materials provided by Federation of American Societies for Experimental Biology. Note: Materials may be edited for content and length.


Journal Reference:

  1. P. Lusso, L. Vangelista, R. Cimbro, M. Secchi, F. Sironi, R. Longhi, M. Faiella, O. Maglio, V. Pavone. Molecular engineering of RANTES peptide mimetics with potent anti-HIV-1 activity. The FASEB Journal, 2011; DOI: 10.1096/fj.10-167627

Cite This Page:

Federation of American Societies for Experimental Biology. "Engineered protein fragment blocks the AIDS virus from entering cells." ScienceDaily. ScienceDaily, 2 April 2011. <www.sciencedaily.com/releases/2011/03/110331114847.htm>.
Federation of American Societies for Experimental Biology. (2011, April 2). Engineered protein fragment blocks the AIDS virus from entering cells. ScienceDaily. Retrieved July 29, 2014 from www.sciencedaily.com/releases/2011/03/110331114847.htm
Federation of American Societies for Experimental Biology. "Engineered protein fragment blocks the AIDS virus from entering cells." ScienceDaily. www.sciencedaily.com/releases/2011/03/110331114847.htm (accessed July 29, 2014).

Share This




More Health & Medicine News

Tuesday, July 29, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Deadly Ebola Virus Threatens West Africa

Deadly Ebola Virus Threatens West Africa

AP (July 28, 2014) West African nations and international health organizations are working to contain the largest Ebola outbreak in history. It's one of the deadliest diseases known to man, but the CDC says it's unlikely to spread in the U.S. (July 28) Video provided by AP
Powered by NewsLook.com
$15B Deal on Vets' Health Care Reached

$15B Deal on Vets' Health Care Reached

AP (July 28, 2014) A bipartisan deal to improve veterans health care would authorize at least $15 billion in emergency spending to fix a veterans program scandalized by long patient wait times and falsified records. (July 28) Video provided by AP
Powered by NewsLook.com
Two Americans Contract Ebola in Liberia

Two Americans Contract Ebola in Liberia

Reuters - US Online Video (July 28, 2014) Two American aid workers in Liberia test positive for Ebola while working to combat the deadliest outbreak of the virus ever. Linda So reports. Video provided by Reuters
Powered by NewsLook.com
Traditional African Dishes Teach Healthy Eating

Traditional African Dishes Teach Healthy Eating

AP (July 28, 2014) Classes are being offered nationwide to encourage African Americans to learn about cooking fresh foods based on traditional African cuisine. The program is trying to combat obesity, heart disease and other ailments often linked to diet. (July 28) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins